| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |